Legend Biotech Net Income 2019-2021 | LEGN

Legend Biotech annual/quarterly net income history and growth rate from 2019 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Legend Biotech net income for the quarter ending September 30, 2021 was $-0.125B, a 87.47% increase year-over-year.
  • Legend Biotech net income for the twelve months ending September 30, 2021 was $-0.355B, a 14.69% increase year-over-year.
  • Legend Biotech annual net income for 2020 was $-0.303B, a 128.23% increase from 2019.
  • Legend Biotech annual net income for 2019 was $-0.133B, a 4676.29% increase from 2018.
  • Legend Biotech annual net income for 2018 was $-0.003B, a INF% decline from .
Legend Biotech Annual Net Income
(Millions of US $)
2020 $-303
2019 $-133
2018 $-3
Legend Biotech Quarterly Net Income
(Millions of US $)
2021-09-30 $-125
2021-06-30 $-92
2021-03-31 $-81
2020-12-31 $-58
2020-09-30 $-67
2020-06-30 $-135
2020-03-31 $-44
2019-12-31 $-64
2019-09-30 $-28
2019-06-30 $-29
2019-03-31 $-12
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.835B $0.076B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.477B 7.93
Bio-Rad Laboratories (BIO.B) United States $23.034B 46.74
QIAGEN (QGEN) Netherlands $12.874B 21.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.457B 0.00
Arcus Biosciences (RCUS) United States $3.257B 0.00
Emergent Biosolutions (EBS) United States $2.378B 8.55
Myovant Sciences (MYOV) United Kingdom $1.780B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.529B 0.00
Zymeworks (ZYME) Canada $0.908B 0.00
Ambrx Biopharma (AMAM) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.345B 0.00
Enzo Biochem (ENZ) United States $0.164B 16.10